FDA Guidance Documents·· 原文未提供具体时分
Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests (Revised): Guidance for Test Developers and Food and Drug Administration Staff
Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests (Revised): Guidance for Test Developers and Food and Drug Administration Staff
AI 导读
FDA 官方历史目录记录；Final guidance；发布日期：2023-01-12。官方主题：Premarket, Coronavirus, IVDs (In Vitro Diagnostic Devices)。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov